Catalent Inc
-
Business
Which stocks might be disrupted next by Ozempic and other GLP-1 drugs
Shares of kidney dialysis providers fell sharply Wednesday after Novo Nordisk said a study showed its Ozempic drug could delay…
Read More » -
Business
Activist Elliott makes inroads at Catalent to build value. Here’s what could happen next
Rows of glass vials in a biologics laboratory in Sweden. Photographer: Mikael Sjoberg/Bloomberg Bloomberg Creative | Bloomberg Creative Photos |…
Read More » -
Business
Wolfe Research says to avoid these names can ruin your portfolio
Wolfe Research warns investors to avoid these potentially explosive low-quality stocks. Using the company’s fourth-quarter results, Wolfe Research identified stocks…
Read More » -
Business
This week’s best-performing stocks include a pharmaceutical name that’s up more than 20%
Wall Street is ending a volatile week, but some stocks are doing well despite some macro volatility. The S&P 500…
Read More » -
Business
Three pharmaceutical stocks increased strongly last week
Global stocks rose last week, tracking US stocks as Wall Street’s main indexes closed with weekly gains. The MSCI World…
Read More »